CVS Grg
Ischemic Heart Disease
Definition: A condition characterized by reduced blood flow to the heart muscle, leading to insufficient oxygen supply.
Types of Ischemic Heart Disease:
Coronary Artery Disease (CAD)
Angina Pectoris
Myocardial Infarction (MI)
Angina Pectoris
Description: Severe chest pain due to inadequate blood supply to the heart muscle.
Causes Agitation and discomfort, indicating ischemia.
Types of Angina:
Classical (Stable) Angina
Triggered by exertion or stress.
Unstable Angina
Occurs at rest or with increased frequency/intensity.
Variant (Prinzmetal) Angina
Caused by vasospasm of coronary arteries.
Pathophysiology:
Plaque formation in blood vessels narrows arteries, impeding blood flow, which prevents the heart from receiving adequate oxygen.
Mechanism of Action:
At rest: Body dilates blood vessels to maintain flow.
During exertion: Blood vessels should further dilate; however, in CAD, they can't due to existing conditions.
Symptoms:
Chest Pain: Described as sensation of pressure or squeezing.
Treatment for Angina
Goals:
Decrease heart workload.
Increase blood flow.
Pharmacological Agents:
Nitrates
Induces vasodilation.
Examples: Glyceryl Trinitrate (GTN), Isosorbide Dinitrate (ISDN).
Mechanism:
Release of nitric oxide (NO) leading to vascular smooth muscle relaxation.
Side effects: Headache, tolerance with frequent doses (requires a nitrate-free interval of 6-8 hours).
Calcium Channel Blockers (CCB)
Example: Diltiazem, Amlodipine.
Mechanism: Prevents calcium influx, causing dilation of blood vessels and decreasing heart rate.
Side Effects: Headache, constipation, gum hypertrophy.
Beta-Blockers
Examples: Metoprolol, Carvedilol.
Mechanism: Reduce heart rate and contractility, decreasing workload.
Anti-spasmodics for variant angina.
Sildenafil (Tadalafil): Caution when combining with nitrates due to the risk of hypotension.
Non-Pharmacological Treatments:
Lifestyle changes: Diet, exercise, and smoking cessation.
Myocardial Infarction (MI)
Definition: A heart attack resulting from prolonged ischemia leading to death of heart muscle tissue.
Symptoms:
Severe chest pain, often radiating to shoulders, neck, arms, jaw.
Nausea, sweating, shortness of breath.
Diagnostic markers: Elevated Troponin levels indicate myocardial damage.
Types of MI Based on ECG:
STEMI: ST-segment Elevation Myocardial Infarction
Full thickness heart muscle damage
Non-STEMI: Partial thickness damage.
Treatment Strategy:
Immediate Treatments:
Morphine, Nitrates, Aspirin to relieve pain and prevent clotting.
Thrombolytics (e.g., Streptokinase) to dissolve clots.
Chronic Management:
Antiplatelet agents (Clopidogrel).
Beta-blockers for cardioprotection.
Statins for cholesterol management.
Special Circumstances & Treatment:
Heart Failure: Inadequate blood flow to tissues despite normal or elevated cardiac output.
Pharmacological management includes diuretics and inotropic agents (e.g., Dopamine, Dobutamine)
Congestive Heart Failure (CHF)
Definition: A condition where the heart cannot pump sufficient blood to meet the body's needs.
Types of CHF:
Systolic Dysfunction
Diastolic Dysfunction
Management Goals:
Fluid management: Diuretics (e.g., Furosemide).
Increase contractility: Inotropic drugs (e.g., Digoxin).
Control heart rate: Beta-blockers and CCB.
Treatment Overview:
Diuretics: Loop diuretics (Furosemide) to relieve edema.
Side Effects: Electrolyte imbalance (hypokalemia).
Inotropics: Increasing cardiac contractility with agents (Dopamine).
Additional Drug Classes in Cardiology
ACE Inhibitors
Example: Lisinopril, Enalapril.
Mechanism: Block conversion of Angiotensin I to II, causing vasodilation, reducing preload & afterload.
Side Effects: Cough, angioedema.
Angiotensin Receptor Blockers (ARBs)
Example: Losartan, Valsartan.
Similar action to ACE inhibitors with fewer side effects.
Direct Vasodilators
Example: Hydralazine, Nitroprusside used in hypertensive emergencies.
Beta-Blockers: Control heart rate and reduce blood pressure. Example: Atenolol.
Renin-Angiotensin-Aldosterone System (RAAS)
Overview: Critical in blood pressure regulation.
Inhibition of RAAS lowers blood pressure and decreases workload of heart, useful in treating hypertension and heart failure.
Conclusion
Understanding ischemic heart diseases, angina, myocardial infarction, and heart failure aids in the development of effective treatment strategies to manage heart conditions and improve patient outcomes.